TTUHSC Researcher Receives NIH Grant for Vaccine

News Release

FOR IMMEDIATE RELEASE
January 5, 2016
CONTACT: Suzanna Cisneros, suzanna.cisneros@ttuhsc.edu
(806) 743-7605

TTUHSC Researcher Receives NIH Grant for Vaccine
Vaccine Could Impact Millions Across the Globe

Texas Tech University Health Sciences Center (TTUHSC) researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health (NIH). The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials. This phase of the research funding is in collaboration with Darrick Carter, president and CEO of PAI Life Science in Seattle, WA.

Over 200 million people suffer from the disease in 74 countries and four times that many are at risk since they do not have access to clean water. A recent discovery in Siddiqui’s TTUHSC research laboratory may make it possible to reduce the number of infections from this disease.

According to the World Health Organization, there are no commercially available vaccines against schistosomiasis, which afflicts people primarily in Asia, Africa and South America.

A person gets a schistosoma infection through contact with contaminated water. The
parasite swims freely in open bodies of water. Once contact is made with humans, the parasite burrows into the skin, matures into another stage, and then migrates to the lungs and liver, where it matures into the adult form.

“Dr. Siddiqui is the quintessential investigator and has brought distinction not only to this research but to our university,” said TTUHSC President Tedd L. Mitchell, M.D. “We are extremely proud of his work and congratulate him on this NIH grant.”

The vaccine, “SchistoShield®” potentially can impact up to one billion people.
Siddiqui also recently received a U.S. patent for the schistosomiasis vaccine. With this NIH grant and an ongoing Bill & Melinda Gates Foundation grant, Siddiqui’s research team has over $7 million in current grant funding and over $11.5 million in total funding thus far on this project.

-30-

Related Stories

TTUHSC’s Graduate School of Biomedical Sciences Hosts Student Research Week

The Texas Tech University Health Sciences Center (TTUHSC) Graduate School of Biomedical Sciences hosted its 34th Annual Student Research Week March 8-11.

TTUHSC Researcher Receives NIH Grant to Study Vulnerabilities in Specific Cancer Types

The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.

The Hype Around Artificial Intelligence

Richard Greenhill, DHA, FISQua, FACHE, discusses the hype and reality surrounding AI in healthcare.

Recent Stories

Health

Living with Dysphagia

Dysphagia is a swallowing disorder that affects a person’s ability to eat or drink, affecting between 300,000 and 700,000 people in the United States each year.

Health

Equip Yourself with Lifesaving Skills – Know How to Stop the Bleed During National Stop the Bleed Month

Brittany Bankhead, M.D., an assistant professor of surgery for the Division of Trauma, Burns and Critical Care at the Texas Tech University Health Sciences Center, said life-threatening bleeding can happen in everyday scenarios.

Education

TTUHSC Celebrates Completion of Physician Assistant Building Expansion

TTUHSC celebrated the completion of the School of Health Professions Physician Assistant Program expansion May 16 with a ceremonial ribbon cutting.